Table 5.
Genetic defect | Endemic fungal pathogen | Gender/age, residence | Clinical manifestations | Other infections and comorbidities | Treatment and outcome | |
---|---|---|---|---|---|---|
IL12RB1 deficiency | ||||||
Moraes-Vasconcelos et al. (138) | Homozygous p.L77F | Paracoccidioides brasiliensis | M/24 years, Brazil | 20 years: fever, hepatosplenomegaly, generalized lymphadenpathy | BCG cervical adenopathy at 7 m, relapse at 2 years 6 years; disseminated non-typhoidal salmonellosis which lasted for 7 years | Treated with trimethoprim-sulfamethoxazole for 5 years with clinical resolution |
de Beaucoudrey et al. (137) | Homozygous p.R521X | Histoplasma spp. | F/5 years | Disseminated histoplasmosis | Tuberculosis | Not mentioned |
Vinh et al. (139) | Homozygous p.C186Y | Coccidioides spp. | Patient 1: F/22 years, US | Diffuse lymphadenopathy (cervical, supraclavicular, hilar, mediastinal, retroperitoneal) | Non-typhoidal salmonellosis (bacteremia and lymphadenopathy) | Fluconazole for 1.5 years without recurrence |
Patient 2 (brother of Patient 1): M/6 years, Arizona, US | 6 years: coccidioidal pneumonia 14 years: right supraclavicular lymphadenopathy and a nasal lesion 16 years: osteomyelitis of the right proximal tibia |
Nil | Received fluconazole for 2 years, developed osteomyelitis 2 months after stopping fluconazole, treated with itraconazole with improvement | |||
Hwangpo et al. (140) | IL12-receptor defect (by functional studies) | Histoplasma spp. | M/8 years | Disseminated histoplasmosis with miliary infiltration of the lungs, mediastinal lymphadenopathy, splenomegaly | Not mentioned | Itraconazole |
Falcão et al. (141) | Homozygous p.R283X | Histoplasma capsulatum | M/4 years, Brazil | 4 years: fever, hepatosplenomegaly, generalized lymphadenopathy, bone marrow involvement 6 years: CNS histoplasmosis complicated by hydrocephalus | Tuberculous adenitis | Antifungal treatment and itraconazole prophylaxis |
Brother of the proband | Disseminated histoplasmosis | Tuberculous adenitis, disseminated salmonellosis | Not mentioned | |||
IFNGR1 defect | ||||||
Zerbe and Holland (146) | Heterozygous c.818del4 | H. capsulatum | M/3 years, Tennessee, US | 3 years: fever, pneumonia, hepatosplenomegaly, cervical and paratracheal lymphadenopathy 4.5 years: fever, pneumonia, generalized lymphadenopathy, sinusitis; lymph node biopsy yielded H. capsulaum 4.8 years: right paranasal mass and osteomyelitis of the facial bones requiring debridement |
Coexisting MAC infection: 3 years: MAC found in gastric aspirate 7 years: cervical lymphadenopathy and osteomyelitis of rib, biopsy yielded MAC |
Repeated courses of intensive antifungal and antimycobacterial therapy, subcutaneous IFN-γ injection led to clearing of all bone lesions. Remained well on prophylactic itraconazole, azithromycin, and IFN-γ |
Vinh et al. (147) | Heterozygous c.818del4 | Coccidioides spp. | M/11 years, Arizona, US | Lobar pneumonia, mediastinal and hilar lymphadenopathy; later developed osteomyelitis involving the vertebral spine and pelvic bone | Mycobacterium chelonae pulmonary infection at 11 months; M. kansasii abscess involving the cervical spine and retropharyngeal space | Refractory coccidioidomycosis with progressive skeletal lesions despite prolonged use of antifungal therapy (amphotericin B and azoles). Surgical debridement with implantation of amphotericin B-impregnated beads. Adjunctive IFN-γ injection for M. kansasii infection with good response |
Lee and Lau (manuscript in preparation) | Homozygous c.182dupT, p.V61fs | Talaromyces marneffei | F/5 months, Chiang Mai, Thailand | Generalized papular skin lesions, hepatosplenomegaly, osteolytic lesions in the skull, fungemia | 11 months: fulminant salmonella septicemia | T. marneffei infection resolved with amphotericin B followed by oral itraconazole; died of salmonellosis and massive lower gastrointestinal bleeding |
Location of residence is indicated wherever information is available.
IFN, interferon; MAC, Mycobacterium avium complex.